NewsMakers in the Biotech Industry Conference to Webcast Millennium
Presentation

Millennium Pharmaceuticals, Inc. logo. (PRNewsFoto)

CAMBRIDGE, MA USA 02/07/2003

CAMBRIDGE, Mass., Sept. 2 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its
presentation at
the NewsMakers in the Biotech Industry Conference will be webcast
live and may
be accessed by visiting the Investors section of the Company's
website,
www.millennium.com.

Millennium senior management will provide an overview of the
Company and
upcoming corporate events. The presentation will be delivered at
1:20 p.m. ET
on Friday, September 9, 2005 from the Sheraton New York Hotel &
Towers in New
York City. The presentation will be archived for 30 days.

About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical
company
based in Cambridge, Mass., markets VELCADE(R) (bortzeomib)
Injection, a novel
cancer product, and has a robust clinical development pipeline of
product
candidates. The Company's research, development and commercialization
activities are focused in three therapeutic areas: oncology,
inflammation, and
cardiovascular. By applying its knowledge of the human genome, its
understanding of disease mechanisms and its industrialized drug
discovery
platform, Millennium is seeking to develop breakthrough products. The
Company's website is www.millennium.com.

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech